Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Infratil (IFT) / FY21

Pacific Radiology Group acquisition adds context to Infratil's result

The NZ$350m acquisition price from the Pacific Radiology Group acquisition is result context, not the main operating signal.

Transport & Infrastructure / Infrastructure investment

IFT revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $1.5b, versus $3.3b in FY25.

IFT Operating profit margin

Operating profit margin across covered periods.

↗
Loading chart...
HY26 was 45.1%, versus 11.9% in FY25.

IFT operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $32.7m, versus $386.4m in FY25.

IFT working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY25 IFT: Outside range low operating working-capital movement. $-56.9m; 3-period range $-2.4m to $47.3m. Operating working-capital movement: NZ$-56.9m, below normal range; 2/3 prior periods had builds averaging NZ$23.9m, and 1 had releases averaging NZ$-2.4m.
  • HY26 IFT: Outside range high operating working-capital movement. $47.3m; 3-period range $-56.9m to $0.5m. Operating working-capital movement: NZ$47.3m, above normal range; 1/3 prior periods had builds averaging NZ$0.5m, and 2 had releases averaging NZ$-29.6m.
Operating working-capital movement: NZ$47.3m, above normal range; 1/3 prior periods had builds averaging NZ$0.5m, and 2 had releases averaging NZ$-29.6m.
Release date
19 May 2021
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY21 vs FY20

Revenue

$1.1b

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net profit after tax

−$49.2m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$91.4m

n/m ↑ vs $0.02m

Final dividend per share

11.5c

-33.3% ↓ vs 17.3c

Profit before tax

−$91.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$133.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

$9.5b

+25.7% ↑ vs $7.6b

What changed

Pacific Radiology Group acquisition is result context, with NZ$350m acquisition price; operating metrics remain the main read

Headline revenue grew n/m to $1.1b, but the comparison is distorted by discontinued-operations classification in both periods — event overlays confirm prior- and current-period reclassifications. The n/m reading is flagged unprecedented in Annolyse's historical baseline against a four-period range of -99.7% to 38.7%, but the move largely reflects which businesses sit in continuing versus discontinued, not underlying growth.

PBT swung from +$523.2m to -$91.8m (-117.6%) and NPAT from +$241.2m to -$49.2m (-120.4%), because the prior year captured $503.6m of Tilt Renewables Australasia result in continuing operations versus $71.6m this year, with discontinued operations now contributing $71.6m after tax.

Pre-lease free cash flow ran at -$368.4m on $459.8m of capex against $91.4m of operating cash flow — below normal range against a three-period mean of -$39.3m.

What matters

The lead profit comparison is a portfolio-reclassification story, not an operating one

PBT growth of -117.6% sits at the lower edge of the four-period historical range. Stripping the prior-year Tilt-linked result from continuing operations, the underlying operating read is much narrower than the -$615m PBT swing suggests, which means the headline NPAT loss should not be taken as a clean indicator of operating deterioration.

Cash generation improved at the operating line but deteriorated at the free-cash-flow line. Operating cash flow climbed to $91.4m from effectively zero, yet capex of $459.8m (43.4% of revenue) produced pre-lease FCF of -$368.4m, $329.1m below the historical mean. This matters because it constrains how much of the dividend and growth investment is internally funded.

Segment results show real operational pressure beneath the reclassification noise. Trustpower NZ's result dropped to $30.8m from $97.7m and Wellington Airport's collapsed to $2.4m from $73.2m on COVID-affected aviation volumes. The dominant segment's earnings compression is invisible in the consolidated revenue line.

Expectations

The interim disclosure forecast FY21 EBITDAF between $430m and $470m, including an $80m COVID-related reduction; release excerpts confirm proportionate EBITDAF of $398.8m from continuing operations, below that range

That undershoot versus the company's own interim guide is the most concrete forward signal in this release and tempers any "trough is behind" reading.

HY21 captured 54.6% of full-year revenue and -56.5% of NPAT, implying second-half revenue of $480.8m and a second-half NPAT loss of $77.0m. The back half got worse on earnings, which matters because it pushes the recovery profile out rather than supporting a clean step-up into FY22.

Quality of result

The result is hard to read as durable because both the revenue jump and the PBT swing reflect classification of Tilt Renewables and other portfolio movements flagged in the event overlays

The cleaner economic reads — Trustpower NZ, Wellington Airport, and pre-lease FCF — all point softer than the headline revenue line.

Operating cash flow of $91.4m is a genuine improvement on the near-zero prior base, but capex absorbs the entirety of it and then some, leaving pre-lease FCF at -$368.4m. Cash on hand of $133.8m and reduced net debt of $876.5m (from $3.2b) reflect announced asset-sale proceeds and capital raising rather than internally funded deleveraging, so the strengthened leverage direction should not be read as recurring operational cash generation.

The 11.5c final dividend is the current-period final component only and is described in release excerpts as a 4.5% increase on the prior final. It should not be compared directly against the 17.25c prior full-year total in the supplied per-share table.

Unresolved

Open questions

What does organic revenue growth look like with Tilt Renewables and other reclassified businesses stripped from both periods on a consistent basis?
Why did proportionate EBITDAF land at $398.8m, below the $430m–$470m interim forecast, beyond the disclosed COVID reduction?
How will capex at 43.4% of revenue trend in FY22, and what is the funding mix between asset-sale proceeds, operating cash flow, and new debt?
Is the dividend covered by internally generated cash given pre-lease FCF of -$368.4m against operating cash flow of only $91.4m?
What recovery path does management see for Wellington Airport and Trustpower NZ, the two segments showing operational compression separate from reclassification?

This briefing cannot assess proportionate EBITDAF segment composition or net-debt covenant headroom without the detailed segment and debt-by-tranche disclosures.

Chat

Ask about IFT FY21

Ask follow-up questions about Infratil's FY21 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about IFT FY21

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Infratil's FY21 result.

What does organic revenue growth look like with Tilt Renewables and other reclassified businesses stripped from both periods on a consistent basis?Why does "The lead profit comparison is a portfolio-reclassification story, not an operating one" matter?How strong was the cash and earnings quality in FY21?What should I watch next for IFT after FY21?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

company filing

FY21 / results announcement↗

Infratil 2021 Annual Report

FY21 / financial report↗

Infratil Full Year Results for the year ended 31 March 2021

FY21 / results release↗

Infratil FY2021 Results Presentation

FY21 / results presentation↗

Prior comparable period

Infratil 2020 Annual Report

FY20 / financial report↗

Interim context

company filing

HY21 / results announcement↗

Infratil Group Interim Financial Statements to 30 September 2020

HY21 / financial report↗

Interim results announcement for the period ended 30 September 2020

HY21 / results release↗

Release context

Agreement to acquire stake in Pacific Radiology Group unconditional

FY21 / commentary↗

Infratil announces agreement to acquire stake in Pacific Radiology Group

FY21 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when IFT publishes next

Get the next Infratil briefing and related NZX reporting-season updates by email.